| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:02 | Adia Nutrition Inc.: Game-Changing Alliance: Adia Labs and Axia | 107 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 10, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today announced a strategic partnership... ► Artikel lesen | |
| Mi | Adia Nutrition Inc. Announces Transformative 2025 Milestones and Strategic Progress Toward Nasdaq Uplisting | 234 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 5, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today recaps its pivotal year-to-date... ► Artikel lesen | |
| 28.10. | Adia Nutrition Inc.: Adia Nutrition Thrilled to Announce to Shareholders Early Q3 Financials Release and Remarkable 200%+ Revenue Growth | 229 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 28, 2025) - Adia Nutrition (OTCQB: ADIA) is thrilled to announce the early release of its Q3 financial results, a powerful testament to the exceptional... ► Artikel lesen | |
| 21.10. | Adia Nutrition Inc. Appoints Dr. Evan Thomas, MD, PhD, to Drive Adia Med's Specialized Treatment Revolution | 99 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is excited to announce the appointment of Evan Thomas, MD, PhD, as an Independent Medical Director for... ► Artikel lesen | |
| 14.10. | Adia Nutrition Inc.: Adia Nutrition Paves Way for Nasdaq and New Investors Through SEC Form 10 Submission | 118 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is thrilled to announce a major milestone in its growth journey. The Company has engaged an independent... ► Artikel lesen | |
| 08.10. | Adia Nutrition Inc. Delivers Explosive Third Quarter Growth: Revenue Surges Over 100% from Prior Quarter, with Remarkable Profit Margin Exceeding 20% | 195 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a trailblazer in umbilical cord stem cells and exosome sales and therapies, today announced phenomenal... ► Artikel lesen | |
| 06.10. | Adia Nutrition sells Biolete coffee subsidiary to focus on healthcare | 2 | Investing.com | ||
| ADIA NUTRITION Aktie jetzt für 0€ handeln | |||||
| 06.10. | Adia Nutrition Inc. Divests Biolete Coffee Subsidiary to Cement Factory LLC, Retains 18% Ownership to Support Strategic Focus on Regenerative Medicine and Medical Sales | 212 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine and innovative healthcare solutions, today announced the sale... ► Artikel lesen | |
| 09.09. | Adia Nutrition Inc.: Adia Nutrition Expands Rapidly, Tripling Sales Force with Regional Teams to Fuel U.S. and Worldwide Growth | 293 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 9, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine, is excited to announce a rapid expansion of its sales operations... ► Artikel lesen | |
| 04.09. | Adia Nutrition Inc. Identifies Over 20 Million Potentially Improperly Issued Shares and Initiates Process to Return Shares to Treasury | 212 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 4, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on advancing stem cell therapies for orthopedics, pain management,... ► Artikel lesen | |
| 02.09. | Adia Nutrition Inc.: Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, and Florida Blue | 454 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 2, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in regenerative medicine, is thrilled to announce a transformative step toward expanding... ► Artikel lesen | |
| 28.08. | Adia Nutrition Inc.: Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market | 170 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine and personalized healthcare, announced that... ► Artikel lesen | |
| 26.08. | Adia Nutrition Inc.: Adia Med Surges Ahead of Growth Timeline With Venture Medical Partnership in $25B Wound Care Market | 215 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 26, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a bold leader in regenerative medicine and personalized healthcare, today announced a thrilling partnership... ► Artikel lesen | |
| 21.08. | Adia Nutrition Inc.: Adia Nutrition Launches Second National Television Campaign Showcasing U.S.-Based Regenerative Stem Cell Therapies | 228 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized healthcare, today announced the launch... ► Artikel lesen | |
| 20.08. | Adia Nutrition Inc.: Adia Med Expands Into Wound Care, Targeting High-Demand $25 Billion Market and Unlocking New Growth Avenues | 234 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 20, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company at the forefront of regenerative medicine and personalized health solutions,... ► Artikel lesen | |
| 06.08. | Adia Nutrition Inc. Celebrates Adia Med's Approval as a UnitedHealthcare Provider in $5.3 Trillion Healthcare Market | 412 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its healthcare clinic, Adia Med, has been officially approved as a provider with... ► Artikel lesen | |
| 06.08. | Adia Nutrition adds glutathione therapies to regenerative medicine portfolio | 1 | Investing.com | ||
| 06.08. | Adia Nutrition Inc.: Adia Med Enters $1.9 Billion Glutathione Industry with Innovative IV and Transdermal Therapies, Expanding High-Demand Offerings | 251 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a rising leader in regenerative medicine, is excited to announce that its subsidiary, Adia Med, is now... ► Artikel lesen | |
| 28.07. | Adia Nutrition Inc. Celebrates Approval as Aetna Health Insurance Provider and Anticipates United Healthcare Approval for Adia Med Subsidiary | 362 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized wellness solutions, is thrilled to announce... ► Artikel lesen | |
| 23.07. | Adia Nutrition Inc. Supports Heroes and Their Families with TRICARE In-Network Application, Advancing Regenerative Care Through Adia Med | 260 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 23, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized wellness solutions, is thrilled to announce... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,360 | +0,16 % | ANALYSE-FLASH: Barclays hebt Ziel für Siemens Healthineers - 'Overweight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Siemens Healthineers von 62 auf 64 Euro angehoben und die Einstufung auf "Overweight" belassen. Klarheit hinsichtlich... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,140 | -0,63 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,910 | +0,57 % | AKTIE IM FOKUS 2: FMC fallen - Erwartung möglicher Platzierung durch Fresenius | (Neu: Weitere Details) FRANKFURT (dpa-AFX Broker) - Die Aktien von Fresenius Medical Care (FMC) sind am Dienstag trotz einer überraschend positiven Geschäftsentwicklung im dritten Quartal unter Druck... ► Artikel lesen | |
| MOVANO | 12,520 | +133,15 % | Corvex To Go Public In All-stock Merger With Movano, Creating A Pure-play Platform For Secure Ai Infrastructure And High-performance Inference | Strategic combination positions combined company to capture AI infrastructure demand at scale
Movano (Nasdaq: MOVE) shareholders gain exposure to rapidly... ► Artikel lesen | |
| GERRESHEIMER | 23,860 | -0,67 % | Aixtron, Gerresheimer, HelloFresh, Hugo Boss, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,240 | +1,15 % | CARL ZEISS MEDITEC AG zündet Kursrakete im TecDAX! | ||
| UNITEDHEALTH | 275,30 | -1,73 % | Here's What Happened to UnitedHealth (UNH) | ||
| PROGYNY | 23,690 | +5,90 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 35,350 | -0,37 % | Zahlen veröffentlicht: Hims & Hers übertrifft Umsatzprognosen: Kommt ein Deal mit Novo Nordisk? | © Foto: Dall-EHims & Hers Health setzt auf Expansion, Diagnostik und einen möglichen Deal mit dem dänischen Pharmariesen Novo Nordisk. Die Aktie steigt nachbörslich deutlich.Das US-amerikanische Telemedizinunternehmen... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,640 | -0,13 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,890 | +2,26 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| DRAEGERWERK | 67,90 | +1,04 % | ANALYSE-FLASH: Jefferies hebt Ziel für Drägerwerk auf 73 Euro - 'Hold' | NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat das Kursziel für Drägerwerk von 67 auf 73 Euro angehoben und die Einstufung auf "Hold" belassen. Das Medizin- und Sicherheitstechnik-Unternehmen habe... ► Artikel lesen | |
| OTTOBOCK | 68,15 | -0,15 % | EQS-DD: Ottobock SE & Co. KGaA: Näder Upside Vermögensverwaltungs GmbH, Verkauf von 593.825 Aktien, die zunächst im Rahmen einer Wertpapierleihe mit Erwerbsoption des Entleihers zur Verfügung ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.11.2025 / 17:35... ► Artikel lesen | |
| STRATEC | 21,750 | +10,74 % | Stratec SE: Lieferengpass trübt den Erholungspfad. Kursziel gesenkt, HALTEN auf KAUFEN. | Stratec SE hat eine Gewinnwarnung herausgegeben, nachdem Störungen in der Lieferkette wesentliche Produktlinien betroffen haben, was zu Verzögerungen und einem schwächeren dritten Quartal führte. Laut... ► Artikel lesen | |
| BETA BIONICS | 27,120 | +3,31 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |